Preclinical evidence that the PPARγ modulator, N-Acetyl-GED-0507-34-Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris-associated damage

J Chéret; I Piccini; J Hardman-Smart; S Ghatak; M Alam; J Lehmann; F Jimenez; H Erdmann; E Poblet; N Botchkareva; R Paus; M Bertolini

doi:10.1111/jdv.16114

Back

Preclinical evidence that the PPARγ modulator, N-Acetyl-GED-0507-34-Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris-associated damage

Journal article

Open access

Preclinical evidence that the PPARγ modulator, N-Acetyl-GED-0507-34-Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris-associated damage

J Chéret, I Piccini, J Hardman-Smart, S Ghatak, M Alam, J Lehmann, F Jimenez, H Erdmann, E Poblet, N Botchkareva, …

Journal of the European Academy of Dermatology and Venereology, Vol.34(4), pp.e195-e197

2020-04

DOI: https://doi.org/10.1111/jdv.16114

PMCID: PMC7154684

PMID: 31774585

Abstract

Hair Follicle - drug effects

Peroxisome Proliferator-Activated Receptors - agonists

Pilot Projects

Lichen Planus - drug therapy

Molecular Targeted Therapy

Humans

Files and links (1)

url

https://doi.org/10.1111/jdv.16114View

Published (Version of record) Open

Metrics

19 Record Views

10 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.158 Dermatology - General; 1.158.1254 Alopecia Areata
Web Of Science research areas: Dermatology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Preclinical evidence that the PPARγ modulator, N-Acetyl-GED-0507-34-Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris-associated damage
Creators: J Chéret - Dr Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
I Piccini - Monasterium Laboratory GmbH, Münster, Germany
J Hardman-Smart - Centre for Dermatology Research, University of Manchester, and NIHR Biomedical Research Centre, Manchester, UK
S Ghatak - Monasterium Laboratory GmbH, Münster, Germany
M Alam - Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Gran Canaria, Spain
J Lehmann - Monasterium Laboratory GmbH, Münster, Germany
F Jimenez - Mediteknia Dermatology Clinic, Las Palmas de Gran Canaria, Gran Canaria, Spain
H Erdmann - Kosmed Klinik, Hamburg, Germany
E Poblet - Department of Pathology, University General Hospital of Murcia, Murcia, Spain
N Botchkareva - Monasterium Laboratory GmbH, Münster, Germany
R Paus - Centre for Dermatology Research, University of Manchester, and NIHR Biomedical Research Centre, Manchester, UK
M Bertolini - Monasterium Laboratory GmbH, Münster, Germany
Publication Details: Journal of the European Academy of Dermatology and Venereology, Vol.34(4), pp.e195-e197
Grant note: Nogra Pharma Ltd.
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
PMID: 31774585
PMCID: PMC7154684
Record Identifier: 991031599407202976